DCC netrin 1 receptor
آخر تحديث 19 May 2025
يتوافق مع الإرشادات التحريرية
- تنزيلتنزيل
- مشاركة
- Language
- نقاش
- نسخة صوتية
- أضف إلى المصادر المفضلة على جوجل
The DCC gene provides instructions for making a protein called the netrin-1 receptor, which is involved in the development of the nervous system. This protein attaches (binds) to a protein called netrin-1, and these two proteins fit together like a lock and key. The binding of netrin-1 to its receptor helps direct the growth of specialized nerve cell extensions called axons. Axons transmit nerve impulses that can signal muscle movement.
Normal function
The DCC gene provides instructions for making a protein called the netrin-1 receptor, which is involved in the development of the nervous system. This protein attaches (binds) to a protein called netrin-1, and these two proteins fit together like a lock and key. The binding of netrin-1 to its receptor helps direct the growth of specialized nerve cell extensions called axons. Axons transmit nerve impulses that can signal muscle movement.
When the brain sends a signal to trigger muscle movement, the signal usually travels from one half of the brain to the opposite side of the body. The binding of netrin-1 to its receptor allows axons to develop this signaling pathway.
The netrin-1 receptor is also thought to act as a dependence receptor, which means it functions differently depending on whether or not it is bound to its protein. When the netrin-1 receptor is bound to netrin-1, it plays a role in nervous system development. When it is not bound to netrin-1, the netrin-1 receptor acts as a tumour suppressor, which means that it keeps cells from growing and dividing too fast or in an uncontrolled way. When the netrin-1 receptor is acting as a tumour suppressor, studies suggest that the netrin-1 receptor triggers the self-destruction of cells when they are no longer needed (apoptosis).
Conditions referring to this gene or chromosome
Other names
CRC18
CRCR1
DCC_HUMAN
IGDCC1
MRMV1
netrin receptor DCC
NTN1R1
tumour suppressor protein DCC
Related patient information and medicines
Patient information leaflet
مرض الكلى السكري
Diabetic kidney disease is common. Around 30 to 40% of people with diabetes (both type 1 diabetes and type 2 diabetes ) develop some form of diabetic kidney disease. Diabetic kidney disease is actually the most common cause of kidney failure in the UK. Around one in five people needing dialysis have diabetic kidney disease, and this will probably.
Patient information leaflet
هل يمكنني تناول ديازيبام وتيرزيباتيد معًا؟
لماذا يحدث هذا Tirzepatide هو a GLP-1 and GIP receptor agonist that delays gastric emptying (the rate at which food and pills leave the stomach). Our Medicines Interaction Checker helps تعتقد check whether your prescriptions, over-the-counter medicines, and supplements are safe to take together. Disclaimer This information is for general.
Patient information leaflet
هل يمكنني تناول الكوديين والمورفين معًا؟
Taking codeine and morphine together significantly increases the risk of serious side effects, including extreme sleepiness, dizziness, and dangerous breathing problems. Why this happens Both codeine and morphine work by attaching to the same receptors in the brain and spinal cord to block pain. لدينا مدقق تفاعلات الأدوية helps you check.
Patient information leaflet
داء الخلايا البدينة واضطرابات الخلايا البدينة
Mast cells يكون hard-working cells that have many functions, including helping to fight infection. However, mast cell disorders can occur in which too many cells are produced or they become overactive. What are the types of mast cell disorder. Mastocytosis This is the term used when too many mast cells are produced. There are many different types.
Patient information leaflet
سرطان الثدي
Ducts. These are channels which take milk from the lobules to the nipple. Fatty tissue and supporting connective tissue. Blood vessels, lymph channels and nerves (like all other areas of the body). Types of breast cancer Carcinoma in situ Some people are diagnosed when the cancerous cells are still totally within a duct or lobule. These are called.
Patient information leaflet
هل يمكنني تناول كويتيابين وفياغرا معًا؟
Quetiapine blocks certain receptors (alpha-1) that help control blood pressure, و Viagra (sildenafil) relaxes blood vessels. Heart conditions and nitrate medications Never take Viagra if you are using nitrate medicines (like glyceryl trinitrate or isosorbide mononitrate) for chest pain or heart failure. إخلاء المسؤولية هذا information is for general.
قراءة إضافية ومراجع
- DCC netrin 1 receptor; MedlinePlus, National Library of Medicine.
- Arakawa H. Netrin-1 and its receptors in tumorigenesis. Nat Rev Cancer. 2004 Dec;4(12):978-87. doi: 10.1038/nrc1504.
- Depienne C, Cincotta M, Billot S, Bouteiller D, Groppa S, Brochard V, Flamand C, Hubsch C, Meunier S, Giovannelli F, Klebe S, Corvol JC, Vidailhet M, Brice A, Roze E. A novel DCC mutation and genetic heterogeneity in congenital mirror movements. Neurology. 2011 Jan 18;76(3):260-4. doi: 10.1212/WNL.0b013e318207b1e0.
- Franz EA, Chiaroni-Clarke R, Woodrow S, Glendining KA, Jasoni CL, Robertson SP, Gardner RJM, Markie D. Congenital mirror movements: phenotypes associated with DCC and RAD51 mutations. J Neurol Sci. 2015 Apr 15;351(1-2):140-145. doi: 10.1016/j.jns.2015.03.006. Epub 2015 Mar 10.
- Gallea C, Popa T, Billot S, Meneret A, Depienne C, Roze E. Congenital mirror movements: a clue to understanding bimanual motor control. J Neurol. 2011 Nov;258(11):1911-9. doi: 10.1007/s00415-011-6107-9. Epub 2011 Jun 3.
- Mehlen P, Llambi F. Role of netrin-1 and netrin-1 dependence receptors in colorectal cancers. Br J Cancer. 2005 Jul 11;93(1):1-6. doi: 10.1038/sj.bjc.6602656.
- Meneret A, Depienne C, Riant F, Trouillard O, Bouteiller D, Cincotta M, Bitoun P, Wickert J, Lagroua I, Westenberger A, Borgheresi A, Doummar D, Romano M, Rossi S, Defebvre L, De Meirleir L, Espay AJ, Fiori S, Klebe S, Quelin C, Rudnik-Schoneborn S, Plessis G, Dale RC, Sklower Brooks S, Dziezyc K, Pollak P, Golmard JL, Vidailhet M, Brice A, Roze E. Congenital mirror movements: mutational analysis of RAD51 and DCC in 26 cases. Neurology. 2014 Jun 3;82(22):1999-2002. doi: 10.1212/WNL.0000000000000477. Epub 2014 May 7.
- Meneret A, Trouillard O, Dunoyer M, Depienne C, Roze E. Congenital Mirror Movements. 2015 Mar 12 [updated 2020 Sep 24]. In: Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK279760/
- Peng J, Charron F. Lateralization of motor control in the human nervous system: genetics of mirror movements. Curr Opin Neurobiol. 2013 Feb;23(1):109-18. doi: 10.1016/j.conb.2012.08.007. Epub 2012 Sep 16.
- Srour M, Riviere JB, Pham JM, Dube MP, Girard S, Morin S, Dion PA, Asselin G, Rochefort D, Hince P, Diab S, Sharafaddinzadeh N, Chouinard S, Theoret H, Charron F, Rouleau GA. Mutations in DCC cause congenital mirror movements. Science. 2010 Apr 30;328(5978):592. doi: 10.1126/science.1186463.
تاريخ المقال
المقال متاح أيضًا باللغة الإنجليزية, الألمانية, إسبانية, الفرنسية, إيطالي, البرتغالية, الهندية, العبرية, العربية ,، و السويدية.
19 May 2025 | أحدث إصدار
1 May 2025 | نُشر في الأصل
انضم إلى المحادثة
شارك أفكارك أو تجاربك مع الآخرين في مجتمعات المرضى.
اسأل، شارك، تواصل.
تصفح المناقشات، اطرح الأسئلة، وشارك التجارب عبر مئات المواضيع الصحية.
اشترك في النشرة الإخبارية للمرضى
جرعتك الأسبوعية من النصائح الصحية الواضحة والموثوقة - مكتوبة لمساعدتك على الشعور بالاطلاع والثقة والتحكم.
من خلال الاشتراك، فإنك تقبل سياسة الخصوصية. يمكنك إلغاء الاشتراك في أي وقت. نحن لا نبيع بياناتك أبدًا.